Coronary artery disease - Risk Factors and Determinants

Risk Factors for Coronary Artery Disease Introduction Coronary artery disease (CAD) develops through a complex interplay of modifiable risk factors (which can be changed through intervention), non-modifiable risk factors (which are inherent to the patient), and environmental exposures. Understanding these risk factors is essential because they drive the atherosclerotic process—the underlying pathology of CAD—and because controlling them is the foundation of disease prevention and management. The risk factors work together synergistically, meaning that having multiple risk factors increases risk more than any single factor alone. This is why comprehensive risk assessment and management is crucial in clinical practice. Classical Modifiable Risk Factors Modifiable risk factors are those that patients and clinicians can change through lifestyle modifications, medications, or both. These are the primary targets of CAD prevention strategies. Hypertension (High Blood Pressure) Elevated blood pressure is one of the most important modifiable risk factors for CAD. Hypertension damages the inner lining of arteries (the endothelium), creating microscopic injuries that allow cholesterol and other substances to accumulate beneath the surface. This accelerates plaque formation and progression. The relationship is dose-dependent—the higher the blood pressure, the greater the risk. Smoking Smoking is particularly dangerous and roughly doubles the risk of CAD, remarkably even at low levels (a single cigarette per day significantly increases risk). Tobacco smoke contains thousands of toxic chemicals that directly injure the endothelium, promote blood clotting, reduce the flexibility of blood vessels, and accelerate atherosclerosis. Importantly, smoking is modifiable, and the cardiovascular benefits of quitting begin within weeks and continue for years. Dyslipidemia (Abnormal Blood Lipids) Elevated low-density lipoprotein (LDL) cholesterol is a major driver of atherosclerotic plaque buildup. LDL particles can become oxidized and trapped in the arterial wall, triggering an inflammatory response that leads to plaque formation. Other lipid abnormalities, such as low HDL cholesterol or elevated triglycerides, also increase risk. Managing lipid levels through diet and medications (primarily statins) is a cornerstone of CAD prevention. Diabetes Mellitus Diabetes markedly increases CAD risk through multiple mechanisms. High blood glucose damages the endothelium, promotes inflammation, accelerates LDL oxidation, and impairs the body's ability to repair vessel walls. Poorly controlled diabetes is especially dangerous. Notably, the CAD risk persists even when LDL cholesterol is relatively well-controlled, suggesting that diabetes contributes to CAD through pathways beyond simple lipid abnormalities. Physical Inactivity Sedentary lifestyle contributes to approximately 7–12% of CAD cases. Physical inactivity worsens multiple other risk factors simultaneously: it promotes weight gain, worsens lipid profiles, raises blood pressure, impairs glucose control, and reduces the body's ability to produce protective substances that support vascular health. Conversely, regular aerobic exercise improves all of these factors. Obesity and Excess Body Weight Obesity (usually defined as a body mass index ≥ 30) accounts for roughly 20% of CAD cases. Excess body fat promotes inflammation, impairs lipid metabolism, worsens insulin resistance, raises blood pressure, and contributes to a pro-thrombotic (clot-promoting) state. Notably, weight loss of even 5–10% of body weight can improve multiple cardiovascular risk factors. Dietary Pattern Diets high in saturated fats, trans fats, and processed foods increase atherosclerotic risk. These dietary patterns worsen lipid profiles and promote systemic inflammation. Conversely, diets rich in vegetables, fruits, whole grains, and lean proteins reduce CAD risk. The exact optimal dietary composition remains debated, but the evidence strongly supports reducing refined carbohydrates and ultra-processed foods while increasing plant-based foods. Excessive Alcohol Consumption Heavy alcohol use worsens cardiovascular risk through multiple mechanisms including elevation of blood pressure, promotion of dangerous arrhythmias, and adverse effects on lipid metabolism. Moderate alcohol consumption (defined as up to one drink daily for women and two for men) may have modest protective effects, though this remains controversial. Psychological Stress and Depression Chronic psychological stress and depression modestly but consistently increase CAD risk. These conditions promote systemic inflammation, increase sympathetic nervous system activity (which elevates heart rate and blood pressure), and may promote behaviors that worsen other risk factors (poor diet, inactivity, smoking). Non-Modifiable Risk Factors Genetic and Familial Factors Approximately 40–60% of CAD risk is heritable, meaning that genetics play a substantial role in determining who develops the disease. A family history of premature CAD (in men before age 55 or women before age 65) is an independent risk factor and suggests both shared genetic susceptibility and potentially shared environmental/lifestyle factors within the family. Age and Sex CAD incidence increases with age in both men and women. Men typically develop CAD at earlier ages than women, though after menopause, women's risk increases substantially. <extrainfo> Specific Genetic Loci Genome-wide association studies have identified multiple genetic loci associated with CAD risk. The 9p21 chromosomal region is one of the most well-replicated genetic risk factors for coronary artery disease, and variants in this region significantly raise disease risk. However, knowing whether a patient carries these variants does not yet have major clinical utility in terms of changing management. Ongoing research aims to understand how these genetic variants affect disease biology and whether genetic testing might eventually improve risk stratification and personalized prevention strategies. </extrainfo> Environmental Exposures Air Pollution Fine particle pollution (PM2.5) from fossil fuel combustion is an increasingly recognized risk factor that accounts for roughly 28% of CAD deaths worldwide. Air pollution promotes endothelial dysfunction, accelerates atherosclerosis, and can trigger acute cardiovascular events. This highlights how environmental factors beyond individual control contribute significantly to CAD burden, especially in regions with heavy industrial activity or high traffic. Systemic Inflammatory Diseases Rheumatologic conditions such as rheumatoid arthritis, systemic lupus erythematosus (SLE), psoriasis, and psoriatic arthritis independently increase CAD risk through chronic systemic inflammation and effects on the vasculature. Patients with these conditions develop atherosclerotic disease earlier and more aggressively than the general population. This association emphasizes the role of inflammation in CAD pathogenesis. Inflammatory Biomarkers While the classical risk factors listed above (hypertension, smoking, cholesterol, etc.) predict CAD risk reasonably well, they do not fully explain who develops disease. Inflammatory markers help fill this gap. Myeloperoxidase Myeloperoxidase (MPO) is an enzyme released by white blood cells (neutrophils and monocytes) during inflammation. Recent research has identified elevated myeloperoxidase as a novel inflammatory biomarker associated with increased CAD risk and with adverse cardiovascular events in patients who already have CAD. Mechanistically, myeloperoxidase contributes to atherosclerosis by catalyzing the oxidative modification of LDL cholesterol, making it more likely to be trapped in artery walls and trigger atherosclerotic plaque development. Measuring myeloperoxidase levels could potentially complement traditional risk markers to better identify high-risk patients, though clinical use remains primarily research-based at this time. <extrainfo> Ongoing research is identifying additional inflammatory biomarkers that might enhance early detection and risk stratification of coronary artery disease, such as high-sensitivity C-reactive protein and IL-6, though these have more established clinical roles than myeloperoxidase. </extrainfo> Summary of Risk Factor Integration The most effective approach to CAD prevention requires simultaneous management of multiple modifiable risk factors. For example, a patient with diabetes should also have their blood pressure controlled, dyslipidemia treated, smoking addressed, and physical activity optimized. This comprehensive approach reduces CAD risk far more effectively than treating any single risk factor in isolation. Additionally, awareness of genetic predisposition and inflammatory markers can help clinicians identify high-risk patients who may benefit from more aggressive preventive strategies. <extrainfo> Emerging Therapeutic Approaches Recent research is exploring whether modulating the immune system could slow or prevent atherosclerosis. Certain immunomodulatory drugs and biologic agents show promise in reducing cardiovascular inflammation in experimental studies and some clinical trials. However, these approaches remain experimental and require careful safety assessment before widespread clinical adoption. The rationale is that since inflammation drives atherosclerosis progression, dampening inflammatory pathways might slow CAD development, particularly in high-risk populations. </extrainfo>